Skip to main content
. 2024 Aug 27;101(1):353–367. doi: 10.3233/JAD-240221

Fig. 3.

Fig. 3

Disposition of participants in the MR DB part and OLE. AE, adverse event; DB, double-blind; MR, Marguerite RoAD; OLE, open-label extension.